M. Brandely

Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy.

A. Monnier, P. Fumoleau, E. Pujade-Lauraine, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Occlusive arteriopathy of the circle of Willis with outlined "Moya-Moya" network in a woman with migraine under oral contraception. Regressive course].

H. Ollat, F. Contamin, M. Brandely, 1983, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.

Intrapleural immunotherapy with escalating doses of interleukin‐2 in metastatic pleural effusions

P. Astoul, F. Rey, J. Viallat, 1993, Cancer.

801 Oral chemotherapy and upper gastro-intestinal tolerance (UGT) improvement of nausea and vomiting in non-small-cell-lung-cancer (NSCLC) patients (pts) treated with oral navelbine (NVB) and standard antiemetic prophylaxis

C. Gridelli, J. Jassem, D. Aubert, 2003 .

Anti‐tumor and immunomodulatory activity of intraperitoneal IFN‐γ in ovarian carcinoma patients with minimal residual tumor after chemotherapy

P. Allavena, A. Mantovani, N. Colombo, 1992, International journal of cancer.

Activity of intrapleural recombinant gamma‐interferon in malignant mesothelioma

F. Varlet, N. van Zandwijk, J. Guerin, 1991, Cancer.

Intrapleural recombinant IL-2 in passive immunotherapy for malignant pleural effusion.

P. Astoul, J. Viallat, C. Boutin, 1993, Chest.

Phase II trial of recombinant interferon gamma in refractory undifferentiated carcinoma of the nasopharynx

T. Tursz, J. Armand, P. Busson, 1993, Head & neck.

Interferon-gamma associated with conventional therapy for recurrent visceral leishmaniasis in a patient with AIDS.

O. Lortholary, P. Babinet, D. Mechali, 1990, Reviews of infectious diseases.

Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy.

A. Monnier, P. Fumoleau, N. Colombo, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.